E-cadherin polymorphisms and breast cancer susceptibility: A report from the Shanghai breast cancer study

Breast Cancer Research and Treatment

Volumn 121, Issue 2, 2010, Pages 445-452

  Beeghly Fadiel, Alicia ^a   Lu, Wei ^b   Gao, Yu Tang ^c   Long, Jirong ^a   Deming, Sandra L ^a   Cai, Qiuyin ^a   Zheng, Ying ^b   Shu, Xiao Ou ^a   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Shanghai Center for Disease Control and Prevention   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

Author keywords

Breast cancer risk; E cadherin; Polymorphisms

Indexed keywords

UVOMORULIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 77953020608     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0579-7     Document Type: Article

References (21)

1. Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does Cadherin dysfunction promote tumor progression? Oncogene 27:6920-6929
2. van RF, Berx G (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65:3756-3788
3. Baranwal S, Alahari SK (2009) Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 384:6-11
4. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC et al (2000) A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60: 873-876
5. Lei H, Sjoberg-Margolin S, Salahshor S, Werelius B, Jandakova E, Hemminki K et al (2002) CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 98:199-204 (Pubitemid 34150802)
6. Cattaneo F, Venesio T, Molatore S, Russo A, Fiocca R, Frattini M et al (2006) Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res 26:4627-4632
7. Wang GY, Lu CQ, Zhang RM, Hu XH, Luo ZW (2008) The E-cadherin gene polymorphism 160C→A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 167:7-14
8. Qiu LX, Li RT, Zhang JB, Zhong WZ, Bai JL, Liu BR et al (2009) The E-cadherin (CDH1)-160 C/A polymorphism and prostate cancer risk: a meta-analysis. Eur J Hum Genet 17:244-249
9. Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF et al (2006) Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. J Biomed Sci 13:419-432
10. Nakamura A, Shimazaki T, Kaneko K, Shibata M, Matsumura T, Nagai M et al (2002) Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 502: 19-24
11. Shin Y, Kim IJ, Kang HC, Park JH, Park HR, Park HW et al (2004) The E-cadherin -347G→GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25: 895-899
12. Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD, Chen WC (2003) Association of E-cadherin gene 3′-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 70:278-281
13. Nasri S, More H, Graziano F, Ruzzo A, Wilson E, Dunbier A et al (2008) A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population. BMC Cancer 8:138
14. Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87:295-300 (Pubitemid 30434361)
15. Beeghly-Fadiel A, Long JR, Gao YT, Li C, Qu S, Cai Q et al (2008) Common MMP-7 Polymorphisms and Breast Cancer Susceptibility: A Multistage Study of Association and Functionality. Cancer Res 68:6453-6459
16. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB et al (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41:324-328
17. The International HapMap Project (2003) Nature 426:789-796
18. de Bakker PIW, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J et al (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38:1166-1172
19. Barrett JC, Fry B, Mailer J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
20. Lin DY, Zeng D, Millikan R (2005) Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 29:299-312
21. Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R et al (2003) Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res 63:5203-5208